Actionable news
0
All posts from Actionable news
Actionable news in INSY: Insys Therapeutics, Inc.,

Insys Therapeutics, Inc.

INSYS Therapeutics, Inc. has a fundamental score of 91 and has a relative valuation of OVERVALUED. INSYS Therapeutics, Inc. appears on the top right hand quadrant of CapitalCube's Value - Price Matrix. We classify this as 'Safety'. In other words, INSYS Therapeutics, Inc. has a relatively high Fundamental Analysis score of 91, while being potentially overvalued and trading higher than its CapitalCube Implied Price of 7.68. There might be some safety in this stock where it's fundamental strength perhaps justifies its relatively higher price.Spreadsheet

INSYS Therapeutics, Inc.'s price of USD 12.15 is...


More